Are you Dr. Spinola?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
545 Barnhill Dr
Eh 435
Indianapolis, IN 46202Phone+1 317-944-8660
Summary
- Dr. Stanley Spinola, MD is an infectious disease specialist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, New York, and North Carolina. He is affiliated with Indiana University Health University Hospital and Richard L. Roudebush Veterans Affairs Medical Center.
Education & Training
University of North Carolina HospitalsResidency, Public Health and General Preventive Medicine, 1984 - 1986- University of North Carolina HospitalsResidency, Pediatrics, 1978 - 1982
Georgetown University School of MedicineClass of 1978
Certifications & Licensure
IN State Medical License 1993 - 2025
NC State Medical License 1978 - 2002
NY State Medical License 1987 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1997
Publications & Presentations
PubMed
- Infections caused byone organism, two stories.Jaffar A Al-Tawfiq, Stanley M Spinola
Clinical Microbiology Reviews. 2024-12-10 - Astrain lacking theiron transport system is virulent in human volunteers.Kate R Fortney, Julie A Brothwell, Teresa A Batteiger, Rory Duplantier, Barry P Katz
Infection and Immunity. 2024-06-11 - 2 citationsFormate production is dispensable forvirulence in human volunteers.Julie A Brothwell, Kate R Fortney, Jalan S Williams, Teresa A Batteiger, Rory Duplantier
Infection and Immunity. 2023-09-14
Press Mentions
Your Healthy Skin Germs Stay Put, Despite CleaningMay 6th, 2016
Skin Microbiome Influences Common Sexually Transmitted DiseaseSeptember 15th, 2015
Grant Support
- Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1995–2012
- Biennial Symposium Of H. Ducreyi Pathogenesis And ChancroidNational Institute Of Allergy And Infectious Diseases2011
- Human Immune Response To Haemophilus Ducreyi InfectionNational Institute Of Allergy And Infectious Diseases2007–2011
- Training In Sexually Transmitted Diseases Including HIVNational Institute Of Allergy And Infectious Diseases2001–2011
- Chancroid Human Challenge Unit (CHCU)National Institute Of Allergy And Infectious Diseases2009
- Biennial Symposium On H.Ducreyi Pathogenesis And ChancroidNational Institute Of Allergy And Infectious Diseases2009
- Administrative CoreNational Institute Of Allergy And Infectious Diseases2009
- Midwest Sexually Transmitted Infections Topical Microbicide Cooperative ResearchNational Institute Of Allergy And Infectious Diseases2007–2009
- Evaluation Of An Weca Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2007–2008
- Biennial Symposium On H.Ducreyi Pathogenesis &ChancroidNational Institute Of Allergy And Infectious Diseases2005–2008
- Chancroid Human Challenge UnitNational Institute Of Allergy And Infectious Diseases2004–2008
- Experimental Human Infection With Haemophilus DucreyiNational Center For Research Resources2000–2008
- Biennial Synposium On H.Ducreyi Pathogenesis &ChancroidNational Institute Of Allergy And Infectious Diseases2006
- Evaluation Of An Dlta Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2006
- Evaluation Of An Ompp2a Ompp2b Double Mutant In Experimental Human InfectionNational Center For Research Resources2005–2006
- Midwest Stis Topical Microbicide Cooperative ResearchNational Institute Of Allergy And Infectious Diseases2004–2006
- Experimental Human Infection With Haemophilus Ducreyi In Persons WHO Are HIVNational Center For Research Resources2004–2006
- Experimental Human Infection With Haemophilus DecreyiNational Center For Research Resources1998–2006
- Evaluation Of A NCAA Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2005
- Evaluation Of Lspa1 &Lspa2 Double Mutant In Exp. Human Infection W/H.DucreyiNational Center For Research Resources2004
- Evaluation Of A Tada Mutant In Experimental Human Infection With H. DucreyiNational Center For Research Resources2004
- Midwest Sexually Transmitted Diseases Cooperative ResearNational Institute Of Allergy And Infectious Diseases1999–2003
- Sialyltransferase Mutant In Experiment Haemophilus InfecNational Center For Research Resources2000–2002
- PAL Mutant In Experimental Haemophilus Ducreyi InfectionNational Center For Research Resources2000–2002
- Major Outer Membrane Protein In Haemophilus DucreyiNational Center For Research Resources2000–2002
- Cytolethal Distending Toxin Mutant In Haemophilus InfectNational Center For Research Resources2000–2002
- CDT &Hemolysin Mutant In Haemophilus Ducreyi InfectionNational Center For Research Resources2000–2002
- Human Immune Response To Haemophilus Ducreyi InfectionNational Institute Of Allergy And Infectious Diseases1995–2002
- Midwest STD Cooperative Research CenterNational Institute Of Allergy And Infectious Diseases1998–2001
- Heptosyltransferase Mutant In Experimental Infection W/ Haemophilus DucreyiNational Center For Research Resources1999
- Hemoglobin Receptor Mutant In Experimental Infection W/ Haemophilus DNational Center For Research Resources1999
- Role Of Hemolysin In Experimental Human Infection With Haemophilus DucreyiNational Center For Research Resources1998–1999
- Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1993–1994
- Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1990–1993
- DO Antibodies Binding To H.8 Prevent MeningococcemiaNational Institute Of Allergy And Infectious Diseases1986
